Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/25/1998US5798366 Treating genetic disorder by administering a 1,5-iminosugar
08/25/1998US5798365 Substituted quinoline derivatives, a process for their preparation, and their use
08/25/1998US5798363 Use for tachykinin antagonists to treat emesis
08/25/1998US5798362 Useful as alpha-adrenoreceptor blockers; condensation
08/25/1998US5798361 5H-thiazolo 3,2-a!pyrimidin-5-one derivatives
08/25/1998US5798360 N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositions
08/25/1998US5798358 Carbostyril derivative
08/25/1998US5798357 Thromboxane synthetase inhibitors
08/25/1998US5798356 Angiostatic compounds
08/25/1998US5798355 Inhibitors of rotamase enzyme activity
08/25/1998US5798354 Cosmetic, therapy
08/25/1998US5798353 Treating eating disorder, obesity, diabetes, psychological disorder, sexual disorder, psychosis, memory disorder
08/25/1998US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer
08/25/1998US5798350 Tricyclic dibenz(b,f)oxepines and dibenzo(b,f)thiepines for treating schizophrenia and anxiety
08/25/1998US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer
08/25/1998US5798345 Method of inhibiting the hyperproliferation of malignant cells
08/25/1998US5798343 Treating gram-negative bacteria with hydrofluoric acid, hydrolyzing or metholyzing, permethylating
08/25/1998US5798342 Use of natural cyclodextrins and their derivatives for the solubilization of platelet anti-aggregating agents from the family of ginkgolides
08/25/1998US5798341 Use of cobalamins for topical treatment of skin disorders
08/25/1998US5798339 Treatment method for cancer
08/25/1998US5798338 Steroid/beta-cyclodextrin clathrate; oxidation resistance
08/25/1998US5798337 Low molecular weight peptidomimetic growth hormone secretagogues
08/25/1998US5798265 Encoding rna complementary to message rna; antisense agents
08/25/1998US5798246 Cyclic nucleotide phosphodiesterase
08/25/1998US5798115 Biocompatible polymer comprising an active drug on polymer backbone; biodegradable, releasing the drug
08/25/1998US5798101 Herbal appetite suppressant and weight loss composition
08/25/1998US5798097 Immunogobulin conjugates
08/25/1998US5798096 Biocompatible hydrogel
08/25/1998US5798093 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
08/25/1998US5798089 Chelant moieties linked to an aryl moiety by an interrupted alkylene linker
08/25/1998US5797906 Retrograde tissue splitter and method
08/25/1998CA2160440C Method of manufacturing non-absorbable synthetic sulfated polysaccharides
08/25/1998CA2147758C Antiparasitic 6,8a-seco deoxyavermectin derivatives
08/25/1998CA2122479C Risedronate delayed-release compositions
08/25/1998CA2122478C Unit dose form of bismuth subsalicylate
08/25/1998CA2121345C Lipophilic oligosaccharide antibiotic salt compositions
08/25/1998CA2107620C Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
08/25/1998CA2087543C Heterocyclic compounds
08/25/1998CA2086247C Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
08/25/1998CA2077420C Imidazoindolizine derivatives and process for preparation thereof
08/25/1998CA2071193C Sulfonamides
08/25/1998CA2031714C R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
08/25/1998CA2006723C Sulfur-containing heterocyclic compounds
08/20/1998WO1998036098A1 Diagnosis and treatment of glaucoma
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998036062A1 Neural cell adhesion molecule splicing variants
08/20/1998WO1998036059A2 Prion propagation inhibition by dominant-negative prion protein mutants
08/20/1998WO1998036002A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035978A1 Aminooxy-modified oligonucleotides
08/20/1998WO1998035977A1 Benzimidazole derivatives
08/20/1998WO1998035973A1 Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions
08/20/1998WO1998035969A1 Alkynyl-substituted camptothecins and process for their preparation
08/20/1998WO1998035968A1 Remedies/preventives for respiratory diseases
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035966A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
08/20/1998WO1998035963A1 Process for preparing eprosartan
08/20/1998WO1998035959A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035958A1 Phthalazines with angiogenesis inhibiting activity
08/20/1998WO1998035957A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998WO1998035956A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035952A1 Oxiran carboxylic acids for the treatment of diabetes
08/20/1998WO1998035951A2 New aminopiperazine derivatives
08/20/1998WO1998035950A1 Benzofurazan compounds which enhance ampa receptor activity
08/20/1998WO1998035949A1 Bicyclic amino acids
08/20/1998WO1998035948A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998WO1998035947A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035946A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035945A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035944A1 Amides as npy5 receptor antagonists
08/20/1998WO1998035943A1 4-aminoethoxyindazole derivatives
08/20/1998WO1998035942A1 4-aminoethoxyindazole derivatives
08/20/1998WO1998035941A1 New benzolactam derivatives and medicinal compositions containing the same
08/20/1998WO1998035940A1 Highly lipophilic camptothecin derivatives
08/20/1998WO1998035937A1 Cetp activity inhibitors
08/20/1998WO1998035935A1 Acrylonitrile compounds, process for their production and pesticides containing them
08/20/1998WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998WO1998035701A1 Drug targeting
08/20/1998WO1998035691A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998WO1998035688A1 Method for destroying retinal pigment epithelial cells
08/20/1998WO1998035685A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
08/20/1998WO1998035683A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
08/20/1998WO1998035682A1 Agent for hormonal contraception and/or treatment and/or prophylaxis of mammary glands with three hormone components
08/20/1998WO1998035681A1 Oxacarbazepine film-coated tablets
08/20/1998WO1998035680A1 Method for the treatment of drug addiction and homeopathic remedy
08/20/1998WO1998035679A1 Stabilization of naloxonhydrochlorid
08/20/1998WO1998035678A1 Use of cyanines, isocyanines and pseudoisocyanines as diuretics
08/20/1998WO1998035676A1 A medicament against infertility and for increasing fertility
08/20/1998WO1998035675A1 Method of using neurotrophic sulfonamide compounds
08/20/1998WO1998035674A1 Compositions for the inhibition of bone resorption
08/20/1998WO1998035672A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate
08/20/1998WO1998035671A1 Remedies for parkinsonism
08/20/1998WO1998035670A1 Product containing idazoxan and 1-dopa as combined pharmaceutical preparation useful for treating parkinson disease
08/20/1998WO1998035668A1 Drugs inhibiting progress of pterygium and postoperative recurrence of the same
08/20/1998WO1998035667A1 Use of nitric oxid synthase inhibitors for the treatment of diabetes
08/20/1998WO1998035666A1 Formulations of nanoparticle naproxen tablets
08/20/1998WO1998035665A1 Counteractive for endotoxin
08/20/1998WO1998035664A1 Athletic endurance increasing agent in food
08/20/1998WO1998035663A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998WO1998035662A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
1 ... 6617 6618 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 6637 ... 7860